Lead, Smoking, and Peripheral Vascular Function
To the Editor:
We read with interest the article by Argacha et al 1 dealing with acute effects of passive smoking on peripheral vascular function. The authors presented data concluding that passive smoking specifically increases aortic wave reflection through a nicotinedependent pathway and impairs microvascular function, even after the end of the exposure. Both tobacco and nontobacco passive smoking inhalation increase plasma asymmetrical dimethyl-arginine levels. 1 It is well documented that exposure to environmental tobacco smoke is a strong contributor to cardiovascular mortality, accounting for Ͼ50 000 deaths annually in the United States. 2 In a recent study from Greece, a 12 times higher lead concentration was found in tobacco smokers than in nonsmokers living in the midaltitudes of the northern hemisphere. 3 In this context, we showed that plasma and intracellular elevated lead concentrations contributed to the development of hypertension because of tobacco or nontabocco smoking or environmental exposure. 4 In addition, in human lymphocytes, elevated lead concentrations with protein denaturation were also found in our studies. 4 This is in concordance with the study from Prozialeck et al 5 showing the vascular system as a target of lead toxicity.
In conclusion, the article by Argacha et al 1 is excellent; however, the role of a lead overload resulting in acute and chronic effects on peripheral vascular function has to be taken in account, too. In addition, we agree that a tobacco-free cigarette cannot be considered as a safe cardiovascular smoke, especially
